MRgLITT is a promising treatment for subcortical, hemorrhagic CMs, offering a minimally invasive approach with low morbidity and favorable clinical outcomes in this preliminary series. https://thejns.org/doi/10.3171/CASE25845.
Jimenez et al. (Mon,) studied this question.